hs-CRP/HDL-C can predict the risk of all cause mortality in cardiovascular-kidney-metabolic syndrome stage 1-4 patients - Han, Fengjiao; Guo, Haiyang; Zhang, Hao; Zheng, Yang (Frontiers in Endocrinology, 2025)